复星医药 (600196.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(复星医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年一季报2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
主要指标:
 营业收入(元) 10,381,939,406.1939,005,086,602.4127,048,280,045.3716,952,397,688.868,056,120,184.4330,306,981,264.1722,102,744,284.0314,028,164,572.105,880,507,166.48
 营业利润(元) 895,946,662.776,313,736,030.604,699,216,894.653,327,733,131.131,159,464,118.494,721,145,273.783,389,970,527.042,322,031,901.56789,580,909.83
 利润总额(元) 887,647,050.276,053,838,409.844,666,207,811.133,304,229,457.361,145,174,540.424,677,844,351.413,360,261,884.902,301,688,451.99769,360,748.53
 净利润(元) 644,285,309.194,987,438,072.293,934,942,143.222,753,581,965.19978,656,638.133,939,979,772.172,749,888,795.261,909,607,412.42648,489,410.05
 归属于母公司股东的净利润(元) 462,512,220.544,735,269,690.833,564,733,323.532,482,372,726.02847,185,598.423,662,812,937.982,478,980,552.001,714,710,154.27577,198,049.34
盈利能力:
 销售毛利率(%) 43.5548.1450.5352.1652.5355.6855.8755.6955.13
 销售净利率(%) 6.2112.7914.5516.2412.1513.0012.4413.6111.03
 净资产收益率(%) 1.2212.439.907.002.41----
 总资产报酬率ROA(%) 1.097.375.924.251.55----
 投入资本回报率ROIC(%) 0.727.635.764.021.396.404.443.091.06
营运能力:
 存货周转率(次) 1.093.802.591.610.82----
 应收账款周转率(次) 1.827.364.783.061.73----
 总资产周转率(次) 0.110.440.320.200.10----
偿债能力:
 资产负债率(%) 50.1348.1546.4046.7745.7545.0550.9850.2948.97
 股东权益比率(%) 40.0242.0143.1242.7943.5244.2141.0741.2142.18
 已获利息倍数(倍) 9.3114.0512.8612.689.917.467.908.986.72
 流动比率 1.021.041.071.041.051.011.011.001.21
 速动比率 0.750.780.790.770.770.730.750.760.92
发展能力:
 营业收入增长率(%) 28.8728.7022.3820.8537.006.024.12-1.02-12.62
 营业利润增长率(%) -22.7333.7338.6243.3146.855.0615.654.71-20.31
 税后利润增长率(%) -45.4129.2843.8044.7746.7810.2720.1213.10-18.97
 净资产增长率(%) 1.675.9417.7014.5915.1716.028.0015.0113.97
 总资产增长率(%) 10.5811.4812.1110.3711.639.942.528.796.65

前瞻产业研究院